Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV

Eitemau Tebyg

• Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
  gan: Hanaoka, Hironari, et al.
  Cyhoeddwyd: (2019)
• Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
  gan: Hironari Hanaoka, et al.
  Cyhoeddwyd: (2018-01-01)
• Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
  gan: Hanaoka, Hironari, et al.
  Cyhoeddwyd: (2018)
• Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study
  gan: Hanaoka, Hironari, et al.
  Cyhoeddwyd: (2017)
• Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV
  gan: Hanaoka, Hironari, et al.
  Cyhoeddwyd: (2017)